Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy

Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy

AIM: To evaluate the efficiency of first-line Helicobacter pylori eradication therapy with glucosаminylmuramyldipeptide (Licopid JSC "Peptek", Russia). /MATERIAL AND METHODS: Eradication therapy was performed in 128 patients (84 men and 34 women; mean age 44.1±13.5 years) with duodenal bul...

Full description

Bibliographic Details
Main Author: M R Konorev
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2012-12-01
Series:Терапевтический архив
Subjects:
duodenal bulb ulcer
h. pylori
eradication
glucosaminylmuramyldipeptide
licopid
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31164

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31164

Similar Items